Circulating microRNAs as biomarkers for diagnosis of early hepatocellular carcinoma associated with hepatitis B virus

Circulating cell-free cancer-testis MAGE-A RNA, BORIS RNA, let-7b and miR-202 in the blood of patients with breast cancer and benign breast diseases

(2014) S A Joosse et al.   BRITISH JOURNAL OF CANCER

MicroRNAs in Hepatocellular Carcinoma: Carcinogenesis, Progression, and Therapeutic Target

(2014) Chao-Hung Hung et al.   Biomed Research International

Serum microRNA-1 and microRNA-122 are prognostic markers in patients with hepatocellular carcinoma

(2013) Verena Köberle et al.   EUROPEAN JOURNAL OF CANCER

Circulating microRNA-22 correlates with microRNA-122 and represents viral replication and liver injury in patients with chronic hepatitis B

(2013) Keiko Arataki et al.   JOURNAL OF MEDICAL VIROLOGY

MicroRNAs: New tools for diagnosis, prognosis, and therapy in hepatocellular carcinoma?

(2012) Silvia Giordano et al.   HEPATOLOGY

Hepatocellular carcinoma

(2012) Alejandro Forner et al.   LANCET

Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre study

(2012) Qiujin Shen et al.   LANCET ONCOLOGY

MicroRNA-122 suppresses cell proliferation and induces cell apoptosis in hepatocellular carcinoma by directly targeting Wnt/β-catenin pathway

(2012) Jie Xu et al.   LIVER INTERNATIONAL

Circulating miR-15b and miR-130b in serum as potential markers for detecting hepatocellular carcinoma: a retrospective cohort study

(2012) Angela M Liu et al.   BMJ Open

Serum miR-122 as a Biomarker of Necroinflammation in Patients With Chronic Hepatitis C Virus Infection

(2011) Verena Bihrer et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Expression of serum miR-221 in human hepatocellular carcinoma and its prognostic significance

(2011) Jipeng Li et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

miR221/222 in Cancer: Their Role in Tumor Progression and Response to Therapy

(2011) M. Garofalo et al.   CURRENT MOLECULAR MEDICINE

Circulating MicroRNAs as Biomarkers for Hepatocellular Carcinoma

(2011) Kevin Z. Qu et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Natural history of chronic hepatitis B REVEALed

(2011) Chien-Jen Chen et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Circulating microRNA-21 as a novel biomarker for hepatocellular carcinoma

(2011) Yoshito Tomimaru et al.   JOURNAL OF HEPATOLOGY

Serum microRNA-122 levels in different groups of patients with chronic hepatitis B virus infection

(2011) O. Waidmann et al.   JOURNAL OF VIRAL HEPATITIS

Serum MicroRNAs as Biomarkers for Hepatocellular Carcinoma in Chinese Patients with Chronic Hepatitis B Virus Infection

(2011) Peng Qi et al.   PLoS One

Serum microRNA Profiles Serve as Novel Biomarkers for HBV Infection and Diagnosis of HBV-Positive Hepatocarcinoma

(2010) L.-M. Li et al.   CANCER RESEARCH

Golgi protein 73 (GOLPH2) is a valuable serum marker for hepatocellular carcinoma

(2010) Yilei Mao et al.   GUT

Clinical significance and potential of hepatic microRNA-122 expression in hepatitis C

(2010) Kazutoyo Morita et al.   LIVER INTERNATIONAL

Circulating MicroRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis

(2010) Jian Xu et al.   MOLECULAR CARCINOGENESIS

miR-221 overexpression contributes to liver tumorigenesis

(2009) P. Pineau et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Analysis of 6381 hepatocellular carcinoma patients in southern Taiwan: prognostic features, treatment outcome, and survival

(2008) Chi-Sin Changchien et al.   JOURNAL OF GASTROENTEROLOGY